Depression in Parkinson’s Disease. CNS Drugs 2000;17;593-600.
Zesiewicz, TA, and RA Hauser. 2000. “Depression in Parkinson’s Disease. CNS Drugs 2000;17;593-600.”. CNS Drugs.
Search
Search results
1934 results found
Modafinil treatment of pramipexole associated somnolence. Movement Disorders 2000;15:1269-1271.
Hauser, RA, MN Wahba, TA Zesiewicz, and WM Anderson. 2000. “Modafinil Treatment of Pramipexole Associated Somnolence. Movement Disorders 2000;15:1269-1271.”. Movement Disorders.
Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson’s disease. Movement Disorders 1998;13:383-393.
Kordower, JH, TB Freeman, EY Chen, EJ Mufson, PR Sanberg, RA Hauser, B Snow, and CW Olanow. 1998. “Fetal Nigral Grafts Survive and Mediate Clinical Benefit in a Patient With Parkinson’s Disease. Movement Disorders 1998;13:383-393.”. Movement Disorders.
Ropinirole for the treatment of early Parkinson’s disease: a 12-month experience. Arch Neurol 1998;55:1211-1216.
Sethi, KD, CF O’Brien, JP Hammerstad, CH Adler, TL Davis, RL Taylor, J Sanchez-Ramos, JM Bertoni, and RA Hauser. 1998. “Ropinirole for the Treatment of Early Parkinson’s Disease: A 12-Month Experience. Arch Neurol 1998;55:1211-1216.”. Arch Neurol.
Borlongan CV, Koutzouzis TK, Freeman TB, Hauser RA, Cahill DW, Sanberg PR. Hyperactivity and hypoactivity in a rat model of Huntington’s disease: the systemic 3-nitropropionic acid model. Brain Research Protocols 1997;1:253-257.
Borlongan, CV, TK Koutzouzis, TB Freeman, RA Hauser, DW Cahill, and PR Sanberg. 1997. “Borlongan CV, Koutzouzis TK, Freeman TB, Hauser RA, Cahill DW, Sanberg PR. Hyperactivity and Hypoactivity in a Rat Model of Huntington’s Disease: The Systemic 3-Nitropropionic Acid Model. Brain Research Protocols 1997;1:253-257.”. Brain Research Protocols.
Adler CH, Sethi KD, Hauser RA, Davis TL, Hammerstad JP, Bertoni J, Taylor RL, Sanchez-Ramos J, O’Brien CF. Ropinirole for the treatment of early Parkinson’s disease. Neurology 1997;49:393-399.
Adler, CH, KD Sethi, RA Hauser, TL Davis, JP Hammerstad, J Bertoni, RL Taylor, J Sanchez-Ramos, and CF O’Brien. 1997. “Adler CH, Sethi KD, Hauser RA, Davis TL, Hammerstad JP, Bertoni J, Taylor RL, Sanchez-Ramos J, O’Brien CF. Ropinirole for the Treatment of Early Parkinson’s Disease. Neurology 1997;49:393-399.”. Neurology.
Infectious issues in human fetal neural transplantation. Cell Transplantation 1997;6:553-556.
Holt, DA, GM Nauert, AL Othberg, TS Randall, AE Willing, RH Widen, RA Hauser, PR Sanberg, CW Olanow, and TB Freeman. 1997. “Infectious Issues in Human Fetal Neural Transplantation. Cell Transplantation 1997;6:553-556.”. Cell Transplantation.
High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor. Ann Neurol 1997;292-299.
Koller, W, R Pahwa, K Busenbark, J Hubble, S Wilkinson, A Lang, P Tuite, et al. 1997. “High-Frequency Unilateral Thalamic Stimulation in the Treatment of Essential and Parkinsonian Tremor. Ann Neurol 1997;292-299.”. Ann Neurol.
Magnetic resonance imaging of corticobasal degeneration. Journal of Neuroimaging 1996;6:222-226.
Hauser, RA, FR Murtagh, K Akhter, M Gold, and CW Olanow. 1996. “Magnetic Resonance Imaging of Corticobasal Degeneration. Journal of Neuroimaging 1996;6:222-226.”. Journal of Neuroimaging.
Manganese and liver disease. Movement Disorders 1996;11:589.
Hauser, RA, and TA Zesiewicz. 1996. “Manganese and Liver Disease. Movement Disorders 1996;11:589.”. Movement Disorders.